Cutaneous malignant melanoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

Authors:

Abstract
The incidence of malignant melanoma varies from 3–5/100 000/year in Mediterranean countries to 12–20/100 000/year in Nordic countries. The mortality rate is 2/100 000/year for females and 3/100 000/year for males with a lesser variation with geography. Melanoma mortality has doubled in males over the last 25 years, during which time a trend of declining incidence and mortality in high-risk Northern European countries combined with a continuing increase in Southern Europe has emerged [1]. Increased ultraviolet-B ray exposure of a genetically predisposed population seems responsible for an ongoing increase in incidence over recent decades [2].

This publication has 17 references indexed in Scilit: